Why the EVOKE Alzheimer’s trial with oral semaglutide failed and what it reveals about GLP-1s, brain aging, and prevention vs treatment.
Category: GLP-1
Here’s what we’ll cover in this blog post: GLP-1 receptor agonists such as Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound) have transformed the treatment of type 2 diabetes and obesity. But now, … Continue reading “Are GLP-1s the First Longevity Drugs?”
Discover how Microdosing GLP-1 alongside LDN may target chronic inflammation, supports immune balance, and offer benefits beyond weight loss.
A simple GLP-1 guide that explains eligibility, dosing, microdosing, and how these medications support metabolic health and longevity.
A guide to GLP-1s for weight loss and longevity. Compare Wegovy, Ozempic, Mounjaro, Tirzepatide, and Zepbound with micro- vs. macro-dosing.
Confused by your medication label? Discover how to read your prescription label and avoid common mistakes for safe, effective treatment.
Discover how Microdosing GLP-1 may reduce inflammation, improve metabolic health, and support longevity by addressing key drivers of aging.
Considering Semaglutide or Tirzepatide for weight loss? Learn who’s most at risk for GLP-1 side effects, and what you can do to stay safe.